Satisfaction of Specific Modes Related to Physical Activity in People Living With Type 1 Diabetes and Using an Hybrid Closed-loop System (BF-ACT)
The BF-ACT study is a single-center, non-interventional (RIPH3) descriptive study conducted at CHU Grenoble Alpes. It aims to evaluate the satisfaction of adults with type 1 diabetes using closed-loop insulin delivery systems, specifically regarding the "physical activity mode" designed to adapt insulin delivery during exercise.
Although physical activity is essential for managing type 1 diabetes, it remains challenging due to the risk of hypoglycemia. Closed-loop systems have improved glucose control, but their effectiveness during exercise depends on multiple factors, and their real-life use can be complex. Currently, little is known about patient satisfaction and experience with these specific modes.
The study will collect data through a self-administered questionnaire, distributed to eligible patients (≥18 years old, with type 1 diabetes, using a closed-loop system for at least 4 months). The primary outcome is the satisfaction score based on the questionnaire. Secondary objectives include describing physical activity perception, usage of the activity mode, and comparing users versus non-users.
Approximately up to 900 patients may be included over a 4-month recruitment period. Clinical and glucose monitoring data will also be collected from medical records. The results are expected to improve patient education, device usability, and support for physical activity in people living with type 1 diabetes.
Studienübersicht
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Quentin Perrier, PharmD, phD
- Telefonnummer: +33 4 76 76 55 16
- E-Mail: qperrier@chu-grenoble.fr
Studienorte
-
-
-
Grenoble, Frankreich
- Rekrutierung
- Chu Grenoble Alpes
-
Kontakt:
- Quentin Perrier, PharmD, phD
- Telefonnummer: +33 4 76 76 55 16
- E-Mail: qperrier@chu-grenoble.fr
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria
- Age ≥ 18 years
- Patient living with type 1 diabetes
- Patient using a closed-loop system for at least 4 months
- Patient followed by a diabetologist in our center
Exclusion criteria
- People opposed to the research
- People protected by the law
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Sonstiges: Only 1 arm = patient treated with AID systems
|
Administration of 1 questionnar to investigate the satisfaction with the physical activity mode of closed-loop systems among people living with type 1 diabetes.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Satisfaction score
Zeitfenster: Baseline
|
Part C, D and E of the questionnar
|
Baseline
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Describe the perception of physical activity within the study population
Zeitfenster: Baseline
|
Part A of the questionnar
|
Baseline
|
|
Describe the proportion of individuals using the physical activity mode in our study
Zeitfenster: Baseline
|
Part B of the questionnar
|
Baseline
|
|
Describe satisfaction with the mode in relation to the physical activities performed by patients
Zeitfenster: Baseline
|
Part F of the questionnar
|
Baseline
|
|
Describe overall satisfaction with the "physical activity" mode
Zeitfenster: Baseline
|
Part G of the questionnar
|
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: HbA1c (%) |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Type of closed-loop system |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Duration of use of the closed-loop system |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Time spent in closed-loop mode |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Duration of type 1 diabetes |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Age |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Sex |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: Body Mass Index (BMI) |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion:
|
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: - Mean glucose (mg/dL) |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: - Glucose Management Index (GMI) |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: - Coefficient of Variation (CV, in %) |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: - Glycemia Risk Index (GRI) |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: - Total daily insulin dose (IU/day) |
Baseline
|
|
Compare populations who use the physical activity mode with those who do not use it
Zeitfenster: Baseline
|
Comparison based on several parameters to describe the two populations at the time of questionnaire completion: CGM data over the 15 days prior to questionnaire completion: - Percentage of use of the physical activity mode |
Baseline
|
Mitarbeiter und Ermittler
Sponsor
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 38RC26.0046
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .